Skip to main content
SpringerLink
Log in

Focal Brachytherapy

  • Chapter
  • First Online:
Technical Aspects of Focal Therapy in Localized Prostate Cancer

  • 664 Accesses

Abstract

Recent data have triggered a worldwide interest in new techniques of “limited” prostate cancer treatment: “focal” techniques that would be able to selectively treat (and eradicate) a well-defined tumoral area of the prostate.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Crook J. The role of brachytherapy in the definitive management of prostate cancer. Cancer Radiother. 2011;15(3):230–7.

    Article  CAS  PubMed  Google Scholar 

  2. Cosset JM, Hannoun-Lévi JM, Peiffert D, Delannes M, Pommier P, et al. Permanent implant prostate cancer brachytherapy: 2013 state-of-the art. Cancer Radiother. 2013;17(2):111–7.

    Article  PubMed  Google Scholar 

  3. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank S, Immerzeel J, et al. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int. 2012;109 Suppl 1:22–9.

    Article  PubMed  Google Scholar 

  4. Salembier C, Lavagnini P, Nickers P, Mangili P, Rijnders A, Polo A, et al.; For the GEC ESTRO PROBATE Group. Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy. Radiother Oncol. 2007;83(1):3–10.

    Google Scholar 

  5. Davis BJ, Horwitz EM, Lee WR, Crook JM, Stock RG, Merrick GS, et al. American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy. Brachytherapy. 2012;11(1):6–19.

    Article  PubMed  Google Scholar 

  6. Hoskin PJ, Rojas AM, Bownes PJ, Lowe GJ, Ostler PJ, Bryant L. Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer. Radiother Oncol. 2012;103(2):217–22.

    Article  PubMed  Google Scholar 

  7. Ghilezan M, Martinez A, Gustason G, Krauss D, Antonucci JV, Chen P, et al. High-dose-rate brachytherapy as monotherapy delivered in two fractions within one day for favorable/intermediate-risk prostate cancer: preliminary toxicity data. Int J Radiat Oncol Biol Phys. 2012;83(3):927–32.

    Article  PubMed  Google Scholar 

  8. Hoskin P, Rojas A, Lowe G, Bryant L, Ostler P, Hughes R, et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. Int J Radiat Oncol Biol Phys. 2012;82(4):1376–84.

    Article  PubMed  Google Scholar 

  9. Sartor AO, Hricak H, Wheeler TM. Evaluating localized prostate cancer and identifying candidates for focal therapy. Urology. 2008;6(Suppl):S12–24.

    Article  Google Scholar 

  10. Jayram G, Eggener SE. Patient selection for focal therapy of localized prostate cancer. Curr Opin Urol. 2009;19:268–73.

    Article  PubMed  Google Scholar 

  11. Polascik TJ, Mouraviev V. Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients. Urology. 2009;74:726–30.

    Article  PubMed  Google Scholar 

  12. Mouraviev V, Mayes JM, Polascik TJ. Pathologic basis of focal therapy for early-stage prostate cancer. Nat Rev Urol. 2009;6:205–15.

    Article  PubMed  Google Scholar 

  13. Tsivian M, Kimura M, Sun L, Mouraviev V, Mayes JM, Polascik TJ. Predicting unilateral prostate cancer on routine diagnostic biopsy: sextant vs extended. BJU Int. 2010;105:1089–92.

    Article  PubMed  Google Scholar 

  14. Langley S, Ahmed HU, Al-Qaisieh B, Bostwick D, Dickinson L, Veiga FG, et al. Report of a consensus meeting on focal low dose rate brachytherapy for prostate cancer. BJU Int. 2012;109 Suppl 1:7–16.

    Article  PubMed  Google Scholar 

  15. Bott SR, Henderson A, Halls JE, Montgomery BS, Laing R, Langley SE. Extensive transperineal template biopsies of prostate: modified technique and results. Urology. 2006;68:1037–41.

    Article  PubMed  Google Scholar 

  16. Taira AV, Merrick GS, Galbreath RW, Andreini H, Taubenslag W, Curtis R, et al. Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting. Prostate Cancer Prostatic Dis. 2010;13:71–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Rastinehad AR, Baccala Jr AA, Chung PH, Proano JM, Kruecker J, Xu S, et al. D’Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol. 2011;185:815–20.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Rosenkrantz AB, Scionti SM, Mendrinos S, Taneja SS. Role of MRI in minimally invasive focal ablative therapy for prostate cancer. Am J Roentgenol. 2011;1:W90–6.

    Article  Google Scholar 

  19. Cosset JM, Cathelineau X, Wakil G, Pierrat N, Quenzer O, Prapotnich D, et al. Focal brachytherapy for selected low-risk prostate cancers: a pilot study. Brachytherapy. 2013;12(4):331–7.

    Article  PubMed  Google Scholar 

  20. Marberger M, Carroll PR, Zelefsky MJ, Coleman JA, Hricak H, Scardino PT, et al. New treatments for localized prostate cancer. Urology. 2008;72(6 Suppl):S36–43.

    Article  PubMed  Google Scholar 

  21. Ahmed HU, Moore C, Emberton M. Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol. 2009;18:219–32.

    Article  PubMed  Google Scholar 

  22. Bozzini G, Colin P, Nevoux P, Villers A, Mordon S, Betrouni N. Focal therapy of prostate cancer: energies and procedures. Urol Oncol. 2013;31(2):155–67.

    Article  CAS  PubMed  Google Scholar 

  23. Bahn DK, Silverman PD. Focal cryoablation of prostate: a review. ScientificWorldJournal. 2008;8:486–91.

    Article  PubMed  Google Scholar 

  24. Chaussy CG, Thüroff S. Transrectal high-intensity focused ultrasound for local treatment of prostate cancer: current role. Arch Esp Urol. 2011;64:493–506.

    PubMed  Google Scholar 

  25. El Fegoun AB, Barret E, Prapotnich D, Soon S, Cathelineau X, Rozet F, et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol. 2011;37:213–9.

    PubMed  Google Scholar 

  26. Chauveinc L, Flam T, Solignac S, Thiounn N, Firmin F, Debré B, et al. Prostate cancer brachytherapy: is real-time ultrasound-based dosimetry predictive of subsequent CT-based dose distribution calculation? A study of 450 patients by the Institut Curie/Hospital Cochin (Paris) Group. Int J Radiat Oncol Biol Phys. 2004;59:691–5.

    Article  PubMed  Google Scholar 

  27. Cosset JM, Flam T, Thiounn N, Gomme S, Rosenwald JC, Asselain B, et al. Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients. Int J Radiat Oncol Biol Phys. 2008;71:1042–8.

    Article  PubMed  Google Scholar 

  28. Haworth A, Williams S, Reynolds H, Waterhouse D, Duchesne GM, Bucci J, et al. Validation of a radiobiological model for low-dose-rate prostate boost focal therapy treatment planning. Brachytherapy. 2013;12:628–36.

    Article  PubMed  Google Scholar 

  29. Kamrava M, Chung MP, Kayode O, Wang J, Marks L, Kupelian P. Focal high-dose-rate brachytherapy: a dosimetric comparison of hemigland vs. conventional whole-gland treatment. Brachytherapy. 2013;12:434–41.

    Article  PubMed  Google Scholar 

  30. Nguyen PL, Chen MH, Zhang Y, Tempany CM, Cormack RA, Beard CJ, et al. Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy. J Urol. 2012;188(4):1151–6.

    Article  PubMed Central  PubMed  Google Scholar 

  31. Barret E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset JM, Validire P, et al. Morbidity of focal therapy in the treatment of localized prostate cancer. Eur Urol. 2013;63(4):618–22.

    Article  CAS  PubMed  Google Scholar 

  32. Gomez-Veiga F, Mariño A, Alvarez L, Rodriguez I, Fernandez C, Pertega S, et al. Brachytherapy for the treatment of recurrent prostate cancer after radiotherapy or radical prostatectomy. BJU Int. 2012;109 Suppl 1:17–21.

    Article  PubMed  Google Scholar 

  33. Peters M, Moman MR, van der Poel HG, Vergunst H, de Jong IJ, Vijverberg PL, et al. Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: a multi-center experience and literature review. World J Urol. 2013;31(2):403–9.

    Article  PubMed  Google Scholar 

  34. Jo Y, Fujii T, Hara R, Yokoyama T, Miyaji Y, Yoden E, et al. Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy – preliminary results. BJU Int. 2012;109(6):835–9.

    Article  PubMed  Google Scholar 

  35. Chen CP, Weinberg V, Shinohara K, Roach 3rd M, Nash M, Gottschalk A. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013;86(2):324–9.

    Article  PubMed  Google Scholar 

  36. Wallace T, Avital I, Stojadinovic A, Brücher BL, Cote E, Yu J. Multi-parametric MRI-directed focal salvage permanent interstitial brachytherapy for locally recurrent adenocarcinoma of the prostate: a novel approach. J Cancer. 2013;4(2):146–51.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Hsu CC, Hsu H, Pickett B, Crehange G, Hsu IC, Dea R, et al. Feasibility of MR imaging/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer. Int J Radiat Oncol Biol Phys. 2013;85(2):370–7.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Institut Mutualiste Montsouris, Paris, 75014, France

    Jean-Marc Cosset

  2. Department of Oncology/Radiotherapy, Institut Curie, Paris, 75005, France

    Jean-Marc Cosset & Noelle Pierrat

Authors
  1. Jean-Marc Cosset
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Noelle Pierrat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Marc Cosset .

Editor information

Editors and Affiliations

  1. Department of Urology, Institut Montsouris, Paris-Descartes University, Paris, France

    Eric Barret

  2. Department of Urology, Hôpital Pasteur 2 – Centre Hospitalier Universitaire de Nice, Antipolis, France

    Matthieu Durand

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag France

About this chapter

Cite this chapter

Cosset, JM., Pierrat, N. (2015). Focal Brachytherapy. In: Barret, E., Durand, M. (eds) Technical Aspects of Focal Therapy in Localized Prostate Cancer. Springer, Paris. https://doi.org/10.1007/978-2-8178-0484-2_13

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0484-2_13

  • Published:

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0483-5

  • Online ISBN: 978-2-8178-0484-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation